Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

1.250 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,122,400
Open 1.270
Bid (Size) 1.230 (19)
Ask (Size) 1.260 (1)
Prev. Close 1.250
Today's Range 1.225 - 1.280
52wk Range 1.150 - 3.110
Shares Outstanding 132,769,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations
From GlobeNewswire News Releases
ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
From GlobeNewswire News Releases

Performance

YTD
-40.76%
-40.76%
1 Month
-3.10%
-3.10%
3 Month
-24.24%
-24.24%
6 Month
-39.02%
-39.02%
1 Year
-44.69%
-44.69%

More News

Read More
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN
From GlobeNewswire News Releases
ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
From GlobeNewswire News Releases
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tags SLNO SNGX ACHL
From Benzinga
Thinking about buying stock in Kadmon Holdings, ADMA Biologics, National CineMedia, Coupa Software, or Gain Therapeutics?
From PR Newswire
ADMA Biologics' Aseptic Fill-Finish Machine Scores FDA Approval
Tags Briefs Market News Penny Stocks
From Benzinga
4 Stocks Insiders Are Selling
Tags Benzinga Trading Ideas ADMA
From Benzinga
ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility
Tags Long Ideas News Briefs
From Benzinga
Thinking about buying stock in Travere Therapeutics, ADMA Biologics, Surgalign, CTI BioPharma, or OpGen?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.